Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease

Abstract

During the budding process, human immunodeficiency virus (HIV) acquires several cellular proteins from the host. Thus, antibodies against self antigens found in sera patients with autoimmune disorders may cross react with host-derived or the HIV-specific proteins gp120 and gp41 on the viral envelope and probably neutralize HIV infection. To verify this hypothesis, 88 sera from HIV negative patients suffering from systemic lupus erythematosus (SLE) and other autoimmune disorders were analysed for cross reacting antibodies against HIV-1 by Western blot and FACS analysis indicating that antibodies cross-react with epitopes expressed on HIV infected or non-infected cells. Virus capture assays revealed that HIV-1_IIIB was directly recognized by 60% of sera from patients with autoimmune disorders. Sera were also tested in HIV neutralization assays with stimulated T cells. Reduction of the viral load by patient sera correlated with their reactivity in Western blot analysis. Complement further enhanced the reduction of viral titres, although no complement-mediated lysis was observed. These data suggest a possible protective role of auto-antibodies against HIV infection in lupus patients.

Keywords

auto-antibodies complement human immunodeficiency virus neutralization systemic lupus eythematosus

Get full access to this article

View all access options for this article.

References

Kyttaris VC , Juang YT , Tsokos GC. Immune cells and cytokines in systemic lupus erythematosus: an update . Curr Opin Rheumatol 2005; 17: 518-522 .

Nagy G , Koncz A , Perl A. T-and B-cell abnormalities in systemic lupus erythematosus . Crit Rev Immunol 2005; 25: 123-140 .

Sekigawa I , Okada M , Ogasawara H et al. Lessons from similarities between SLE and HIV infection . J Infect 2002; 44: 67-72 .

Abuaf N , Laperche S , Rajoely B et al. Autoantibodies to phospholipids and to the coagulation proteins in AIDS . Thrombosis and Haemostasis 1997; 77: 856-861 .

Kopelman RG , Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena . Am J Med 1988; 84: 82-88 .

Strauss J , Abitbol C , Zilleruelo G et al. Renal disease in children with the acquired immunodeficiency syndrome . New Engl J Med 1989; 321: 625-630 .

D’Agati V , Seigle R. Coexistence of AIDS and lupus nephritis: a case report . Am J Nephrol 1990; 10: 243-247 .

Furie RA. Effects of human immunodeficiency virus infection on the expression of rheumatic illnes . Rheum Dis Clin North Am 1991; 17: 177-188 .

Yeh CK , Fox PC , Goto Y , Austin HA , Brahim JS , Fox CH. Human immunodeficiency virus (HIV) and HIV infected cells in saliva and salivary glands of a patient with systemic lupus erythematosus . J Rheumatol 1992; 19: 1810-1812 .

10.

Bambery P , Deodhar DD , Malhotra HS , Sehgal S. Blood transfusion related HBV and HIV infection in a patient with SLE . Lupus 1993; 2: 203-205 .

11.

Itoh K , Nishioka Y , Hirohata S et al. HIV induced systemic lupus erythematosus . Lupus 1994; 3: 205-206 .

12.

Lu I , Cohen PR , Grossman ME. Multiple dermatofibromas in a woman with HIV infection and systemic lupus erythematosus . J Am Acad Dermatol 1995; 32: 901-903 .

13.

Maradona JA , Carton CA , Asensi V. Mysthenia gravis and systemic lupus erythematosus in association with human immunodeficiency virus infection . Clin Infect Dis 1995; 20: 1577-1578 .

14.

Molina JF , Citera G , Rosler D et al. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus . J Rheumatol 1995; 22: 347-350 .

15.

Byrd VM , Sergent JS. Suppression of systemic lupus erythematosus by the human immunodeficiency virus . J Rheumatol 1996; 23: 1295-1296 .

16.

Cimmino MA , de Maria A , Moggiana G , Parisi M , Querci G , Accardo S. HIV infection in a male patient with systemic lupus erythematosus . Clin Exp Rheumatol 1996; 14: 317-320 .

17.

Contreras G , Dollie GF , Pardo V , Schultz DR , Bour-giognie JJ. Systemic lupus erythematosus in two adults with human immunodeficiency virus infection . Am J Kidney Dis 1996; 28: 292-295 .

18.

Kudva KC , Lynne PS , Holley KE , Wright AJ , Hunder GG. SLE nephropathy in a patient with HIV infection: case report and review of the literature . J Rheumatol 1996; 23: 1811-1815 .

19.

Fernández-Mirand C , Rubio R , Pulido F. Development of acquired immune deficiency syndrome in a patient with systemic lupus erythemaotusus . J Rheumatol 1996; 23: 1308-1308 .

20.

Fox FA , Isenberg DA. Human immunodeficiency virus infection in systemic lupus erythematosus . Arthritis Rheum 1997; 40: 1168-1172 .

21.

Chang BG , Markowitz GS , Seshan SV , Seigle RL , D’Agati VD. Renal manifestations of concurrent systemic lupus erythematosus in HIV infection . Am J Kidney Dis 1999; 33: 441-449 .

22.

Clutterbuck DJ , Watson J , De Ruiter A , Godfrey T , Bradbeer C. Presence of HIV infection in patients diagnosed with systemic lupus erythematosus . Rheumatology 2000; 39: 1047-1048 .

23.

Diri E , Lipsky PE , Berggren RE. Emergence of lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection . J Rheumatol 2000; 27: 2711-2714 .

24.

Calza L , Manfredi R , Colangeli V , D’Antuono A , Passarini B , Chiodo F. Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy . Int J STD AIDS 2003; 14: 356-359 .

25.

Sommer S , Piyadigamage A , Goodfield MJ.

Systemic lupus erythematosus or infection with HIV, or both?

Clin Exp Dermatol 2004; 29: 393-395 .

26.

Palacios R , Santos J , Valdivielso P , Marquez M. Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature . Lupus 2002; 11: 60-63 .

27.

Daikh BE , Holyst MM. Lupus-specific autoantibodies in concomitant human immunodeficiency virus and systemic lupus erythematosus: case report and literature review . Semin Arthritis Rheum 2001; 30: 418-425 .

28.

Wanchu A , Sud A , Singh S , Bambery P. Human immunodeficiency virus infection in a patient with systemic lupus erythematosus . J Assoc Physicians India 2003; 51: 1102-1104 .

29.

Barthel HR , Wallace DJ. False positive human immunodeficiency virus testing in patients with lupus erythematosus . Semin Arthritis Rheum 1993; 23: 1-7 .

30.

Sekigawa I , Lee S , Kaneko H et al. The possible role of interleukin-16 in the low incidence of HIV infection in patients with systemic lupus erythematosus . Lupus 2000; 9: 155-156 .

31.

Zangerle R , Steinhuber S , Sarcletti M et al. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals . Int Arch Allergy Immunol 1998; 116: 228-239 .

32.

Frank I , Stoiber H , Godar S et al. Acquisition of host cell-surface-derived molecules by HIV-1 . AIDS 1996; 10: 1611-1620 .

33.

Purtscher M , Trkola A , Gruber G et al. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1 . AIDS Res Hum Retroviruses 1994; 10: 1651-1658 .

34.

Spruth M , Stoiber H , Kacani L , Schonitzer D , Dierich MP. Neutralization of HIV type 1 by alloimmune sera derived from polytransfused patients . AIDS Res Hum Retroviruses 1999; 15: 533-543 .

35.

Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection . Semin Arthritis Rheum 2000; 30: 147-166 .

36.

Palacios R , Santos J , Valdivielso P , Marquez M. Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature . Lupus 2002; 11: 60-63 .

37.

Calza L , Manfredi R , Colangeli V , Chiodo F. Systemic lupus erythematosus and HIV infection. A case report and review of the literature . Recenti Prog Med 2002; 93: 28-31 .

38.

Diri E , Lipsky PE , Berggren RE. Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection . J Rheumatol 2000; 27: 2711-2714 .

39.

40.

Font J , Vidal J , Cervera R et al. Lack of relationship between human immunodeficiency virus infection and systemic lupus erythematosus . Lupus 1995; 4: 47-49 .

41.

Povolotsky J , Polsky B , Laurence J , Jindal R , Rozon-Solomon M , Burrows L. Withdrawal of conclusion: false positive tests for HIV in a woman with lupus . N Engl J Med 1994; 331: 881-882 .

42.

Adelman MK , Marchalonis JJ. Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses . Clin Immunol 2002; 102: 107-116 .

43.

Kaye BR. Rheumatologic manifestations of HIV infections . Clin Rev Allergy Immunol 1996; 14: 385-416 .

44.

Gonzalez CM , Lopez-Longo FJ , Samson J et al. Antiribonucleoprotein antibodies in children with HIV infection: a comparative study with childhood-onset systemic lupus erythematosus . AIDS Patient Care STDS 1998; 12: 21-28 .

45.

Rodriguez-Mahou M , Lopez-Longo J , Lapointe N et al. Autoimmune phenomena in children with human immunodeficiency virus infection and acquired immunodeficiency syndrome . Acta Paediatr Suppl 1994; 400: 31-34 .

46.

Pinto LA , Dalgleish AG , Sumar N , Poulton TA. Panel of anti-gp120 monoclonal antibodies reacts with same nuclear proteins in uninfected cells as those recognized by autoantibodies from patients with systemic lupus erythematosus . AIDS Res Hum Retroviruses 1994; 10: 823-828 .

47.

Talal N , Garry RF , Schur PH et al. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus . J Clin Invest 1990; 85: 1866-1871 .

48.

Stoiber H , Thielens NM , Ebenbichler C , Arlaud GJ , Dierich MP. The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1 and share antigenic homology . Eur J Immunol 1994; 24: 294-300 .

49.

Stoiber H , Ebenbichler CF , Schneider R , Janatova J , Dierich MP. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1 . AIDS 1995; 9: 19-26 .

50.

Golding H , Robey FA , Gates FT 3rd et al. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients’ sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome . J Exp Med 1988; 167: 914-923 .

51.

Golding H , Shearer GM , Hillman K et al. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals . J Clin Invest 1989; 83: 1430-1435 .

52.

Gul A , Inanc M , Yilmaz G et al. Antibodies reactive with HIV-1 antigens in systemic lupus erythematosus . Lupus 1996; 5: 120-122 .

53.

Wilfingseder D , Spruth M , Ammann CG et al. Complement-mediated enhancement of HIV-1 neutralisation by anti-HLA antibodies derived from polytransfused patients . Int Arch Allergy Immunol 2003; 131: 62-72 .

54.

Stoiber H , Kacani L , Speth C , Wurzner R , Dierich MP. The supportive role of complement in HIV pathogenesis . Immunol Rev 2001; 180: 168-176 .